UnitedHealth Group Incorporated

Analyst Ratings Synthesis

The supplied consensus is Buy across 23 analysts. Its reported target fields are internally inconsistent, listing a low of $468, a mean of $490 and a high of $468, so they do not establish a valid target range; other supplied aggregators show a $475.23 average for 27 analysts and a $287-$492 range, while MarketBeat reports $455.92. Bernstein is the most bullish named analyst at $492 with an Outperform rating, and Deutsche Bank is the least bullish at $360 with a Hold rating. The evidence points to a constructive outlook following UnitedHealth’s raised 2026 guidance, but it does not identify any attributable rating or target revisions during this week. The substantive disagreement is whether medical-cost pressure will fade quickly enough to restore earnings power.

• UnitedHealth: It's Time To Buy This Recovery (NYSE:UNH)
• Employer Health Costs Surge: What it Means for EHTH, CNC & UNH
• Goldman Sachs, UnitedHealth And A Tech Stock On CNBC’s ‘Final Trades’
• Employer Health Costs Surge: What it Means for EHTH, CNC & UNH
• UnitedHealth, Applied Materials, Citigroup Stocks Surged To 52-Week Highs Today: What Drove The Uptick?